PCSA — Processa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Processa Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	15.4	16.5	6.5	4.71	1.19
Net Total Receivables	0.232	0.07	—	—	—
Prepaid Expenses
Total Current Assets	16.2	18.3	8.39	5.63	1.87
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.159	0.074	0.228	0.149	0.076
Net Intangible Assets
Other Long Term Assets
Total Assets	25.2	26.5	8.62	5.79	3.23
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.22	0.971	0.999	0.731	1.53
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2.27	0.978	1.15	0.797	1.53
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	22.9	25.5	7.47	4.99	1.7
Total Liabilities & Shareholders' Equity	25.2	26.5	8.62	5.79	3.23
Total Common Shares Outstanding